7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon
11 June 2006. Related: Conference reports.
PK Workshop 7th 2006
Efavirenz levels above recommended upper target in 20% of African patients in Senegal
11 June 2006. Related: Conference reports, Antiretrovirals.
Lower dose of AZT provides adequate exposure in patients with low body weight
11 June 2006. Related: Conference reports, Antiretrovirals.
Pharmacokinetics for generic fixed dose combinations for children are comparable to the branded products
11 June 2006. Related: Conference reports, Paediatric care.
Caution against dividing adult FDCs (Triomune) for young children
11 June 2006. Related: Conference reports, Paediatric care.
University of Liverpool audit of paediatric TDM
11 June 2006. Related: Conference reports, Paediatric care.
Age-dependent pharmacokinetics of 3TC in children
11 June 2006. Related: Conference reports, Paediatric care.
Use of small sample drug level monitoring for paediatric PI concentrations
11 June 2006. Related: Conference reports, Paediatric care.
Intracellular and plasma measurements of AZT and 3TC and their metabolites in neonates
11 June 2006. Related: Conference reports, Paediatric care.
Effect of pregnancy on PK of protease inhibitors
11 June 2006. Related: Conference reports, Pregnancy.
Using enzyme inducers to reduce the half-life of nevirapine
11 June 2006. Related: Conference reports.
Relationship between nevirapine concentrations and virological failure in a clinical setting
11 June 2006. Related: Conference reports, PK and drug interactions.
Summary of drug interaction studies
11 June 2006. Related: Conference reports, PK and drug interactions.
Effects of ketoconazole and rifampin on TMC278
10 June 2006. Related: Conference reports, PK and drug interactions.
Brecanavir interaction study with ritonavir and atazanavir
10 June 2006. Related: Conference reports, PK and drug interactions.
Fixed-dose formulation of efavirenz/tenofovir/FTC bioequivalent to separate dosing
10 June 2006. Related: Conference reports, Antiretrovirals.
Saquinavir/r (1000/100mg) levels reduced when taken fasted and should be taken with food
10 June 2006. Related: Conference reports, Antiretrovirals.
Lack of food effect with Meltrex formulation of lopinavir/r
10 June 2006. Related: Conference reports, Antiretrovirals.
Food interaction reduces ddI intracellular absorption and supports requirement to take fasted
10 June 2006. Related: Conference reports, Antiretrovirals.
Conflicting results on how T-20 affects tipranavir
10 June 2006. Related: Conference reports, Antiretrovirals.